BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30082728)

  • 1. TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells.
    Elster D; Tollot M; Schlegelmilch K; Ori A; Rosenwald A; Sahai E; von Eyss B
    Nat Commun; 2018 Aug; 9(1):3115. PubMed ID: 30082728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers.
    Serandour AA; Mohammed H; Miremadi A; Mulder KW; Carroll JS
    Oncogene; 2018 Sep; 37(39):5281-5291. PubMed ID: 29895970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.
    Zhu C; Li L; Zhang Z; Bi M; Wang H; Su W; Hernandez K; Liu P; Chen J; Chen M; Huang TH; Chen L; Liu Z
    Mol Cell; 2019 Aug; 75(4):791-806.e8. PubMed ID: 31303470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.
    Bach AS; Derocq D; Laurent-Matha V; Montcourrier P; Sebti S; Orsetti B; Theillet C; Gongora C; Pattingre S; Ibing E; Roger P; Linares LK; Reinheckel T; Meurice G; Kaiser FJ; Gespach C; Liaudet-Coopman E
    Oncotarget; 2015 Sep; 6(29):28084-103. PubMed ID: 26183398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer.
    Witwicki RM; Ekram MB; Qiu X; Janiszewska M; Shu S; Kwon M; Trinh A; Frias E; Ramadan N; Hoffman G; Yu K; Xie Y; McAllister G; McDonald R; Golji J; Schlabach M; deWeck A; Keen N; Chan HM; Ruddy D; Rejtar T; Sovath S; Silver S; Sellers WR; Jagani Z; Hogarty MD; Roberts C; Brown M; Stegmaier K; Long H; Shivdasani RA; Pellman D; Polyak K
    Cell Rep; 2018 Oct; 25(5):1255-1267.e5. PubMed ID: 30380416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
    Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
    Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
    J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association between YAP/TAZ/TEAD andĀ AP-1 at enhancers drives oncogenic growth.
    Zanconato F; Forcato M; Battilana G; Azzolin L; Quaranta E; Bodega B; Rosato A; Bicciato S; Cordenonsi M; Piccolo S
    Nat Cell Biol; 2015 Sep; 17(9):1218-27. PubMed ID: 26258633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter.
    Piscopo DM; Johansen EB; Derynck R
    J Biol Chem; 2009 Nov; 284(46):31690-703. PubMed ID: 19759027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
    Shen J; Cao B; Wang Y; Ma C; Zeng Z; Liu L; Li X; Tao D; Gong J; Xie D
    J Exp Clin Cancer Res; 2018 Jul; 37(1):175. PubMed ID: 30055645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifaceted function of YAP/TEAD on chromatin:prospects of 'A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer'.
    Chen L; Liu Z
    J Mol Cell Biol; 2019 Dec; 11(12):1101-1103. PubMed ID: 31774121
    [No Abstract]   [Full Text] [Related]  

  • 12. TEAD mediates YAP-dependent gene induction and growth control.
    Zhao B; Ye X; Yu J; Li L; Li W; Li S; Yu J; Lin JD; Wang CY; Chinnaiyan AM; Lai ZC; Guan KL
    Genes Dev; 2008 Jul; 22(14):1962-71. PubMed ID: 18579750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A central role for TRPS1 in the control of cell cycle and cancer development.
    Wu L; Wang Y; Liu Y; Yu S; Xie H; Shi X; Qin S; Ma F; Tan TZ; Thiery JP; Chen L
    Oncotarget; 2014 Sep; 5(17):7677-90. PubMed ID: 25277197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
    Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
    FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
    Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
    Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
    Liu J; Li J; Li P; Wang Y; Liang Z; Jiang Y; Li J; Feng C; Wang R; Chen H; Zhou C; Zhang J; Yang J; Liu P
    Sci Rep; 2017 Feb; 7():42125. PubMed ID: 28169360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells.
    Davaadelger B; Murphy AR; Clare SE; Lee O; Khan SA; Kim JJ
    Endocrinology; 2018 Oct; 159(10):3581-3595. PubMed ID: 30203004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPS1 drives heterochromatic origin refiring and cancer genome evolution.
    Yang J; Liu X; Huang Y; He L; Zhang W; Ren J; Wang Y; Wu J; Wu X; Shan L; Yang X; Sun L; Liang J; Zhang Y; Shang Y
    Cell Rep; 2021 Mar; 34(10):108814. PubMed ID: 33691114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.
    Lamar JM; Stern P; Liu H; Schindler JW; Jiang ZG; Hynes RO
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2441-50. PubMed ID: 22891335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.